Linked research, clinical, and regulatory source pathways.
Company profile
About Ro
Ro is a comprehensive digital health platform that delivers personalized healthcare solutions directly to consumers through a fully online experience. The company specializes in multiple therapeutic areas including weight management with GLP-1 medications (Wegovy, Ozempic, Zepbound, Foundayo), sexual health treatments for erectile dysfunction and premature ejaculation, hair loss solutions for both men and women, dermatological care, and fertility support. Ro's platform connects patients with US-licensed healthcare providers for virtual consultations, enabling prescription treatments to be delivered discreetly to patients' homes. The company operates on a membership model with the Ro Body program for weight loss and offers both prescription medications and over-the-counter products. With over 3 million members, Ro emphasizes convenience, affordability, and accessibility, providing 24/7 provider messaging, free shipping, and comprehensive support throughout treatment journeys. The platform is backed by board-certified physicians and medical advisors with expertise spanning obesity medicine, internal medicine, and surgical specialties from institutions like Stanford, Johns Hopkins, and Yale. Ro's approach combines clinical rigor with consumer-friendly technology to make healthcare more accessible and affordable, particularly for conditions that have traditionally carried stigma or required in-person visits.
Company description Ro official website
Primary marketTelemedicine & Virtual Care
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Ro?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Acne
- Cold Sores
- Erectile Dysfunction
- Fertility Issues
- Genital Herpes
- Hair Loss (Male and Female Pattern)
- Obesity/Overweight
- Photoaging
- Premature Ejaculation
- Short Lashes
- Telogen Effluvium
- Testosterone Deficiency
Who it serves
- Direct-to-consumer patients
- Individual consumers seeking telehealth services
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Launch of new GLP-1 options including Wegovy pill, Foundayo pill, and Zepbound KwikPen. Introduction of 'TrumpRx pricing' for GLP-1 medications. Expansion to over 3 million members. Launch of Ro Body membership program for weight loss.
Partnerships
Recorded partners
- Charles Barkley (Brand Ambassador)
- Serena Williams (Brand Ambassador)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Determination of cardiopulmonary resuscitation quality based on machine learning algorithms using various biological signals.Health information science and systems · Dec 1, 2026
Long-term physical and mental health effects of unresolved disaster-related bereavement: evidence from an 8-year propensity score-matched cohort study.European journal of psychotraumatology · Dec 1, 2026
Circular RNAs in tumorigenesis: an insight into recent research in biogenesis and targeted tumor therapy.Cell cycle (Georgetown, Tex.) · Dec 1, 2026
Eligibility-trace-gated depression in predecessor feature learning enables post-reward exploration.Cognitive neurodynamics · Dec 1, 2026
Self-management in Korean immigrants with type 2 diabetes in the United States: a systematic review.Journal of diabetes and metabolic disorders · Dec 1, 2026
Evaluation of dietary curcumin-loaded mesoporous silica nanoparticles on growth, blood biochemistry, gut barrier integrity and enteric gas emissions in weaned piglets.Veterinary and animal science · Dec 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
340% increase in time to orgasm
Roman Swipes for premature ejaculation over 2 months
20% body weight reduction
GLP-1 weight loss treatments
Hair regrowth in 3-6 months
Hair Solution Rx with minoxidil
95% member satisfaction
Overall patient experience
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Ro
Recent articles published on Ro's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Telemedicine & Virtual Care
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.